Pet Medication Market Analysis and Business Opportunities with CAGR Value, Key Manufactures, Revenue Structure, Types, Applications

The Pet Medication market report gives CAGR value, SWOT Analysis, Industry Chains, Mergers & Acquisitions, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Production, Consumption, Application, Competitor analysis and Forecast.

Dublin, United States - February 12, 2019 /MarketersMedia/ —

Pet medication is the field of medicine that deals with the diagnosis, prevention, and treatment of diseases, injuries, and disorders in pet animals. The market for pet medication displayed impressive growth over the past few years and it has become a vital part of the veterinary industry. Prescription and over-the-counter drugs have witnessed a rapid growth over the past five years. Veterinarians enjoyed the monopoly of prescription and over-the-counter medicines. However, the 90s marked a notable change in the sale of pet medicines when brick & mortar stores and e-commerce started taking over the sale of pet medicines.

The market for pet medication is mainly driven by increasing pet adoption across the globe. There were approximately 90 million pet dogs present in the U.S. in 2017. Changing cultural and socio-economic factors have led to pet animals being considered as an integral member of the family. This has led to a significant increase in pet expenditure. Further, the growing trend of the nuclear family is another major factor responsible for the growth of the pet medication market at present. However, rising prices of pet medicines and rising incidences of pet allergies are some of the factors responsible for the slowdown of the market.

North America and Europe are matured markets for pet medication. High pet adoption in these regions, coupled with frequent launch of new drugs and availability of pet insurance are some of the major factors aiding in the growth of the pet medication market in these regions. However, emerging nations in the Asia-Pacific region are expected to display a higher growth rate for pet medication during the forecast period. The growing base of affluent middle-class population and the willingness to have a reciprocative relationship with pets to fill relationship voids are some of the factors driving market growth for pet medication in the Asia Pacific. China, Japan, and India are expected to lead the growth of the market in the coming years.

The Pet Medication market by Manufacturers: Zoetis, Merck, Merial, Elanco, Bayer, Boehringer, Novartis, Virbac, Ceva, Vetoquinol, Nexvet, Aratana Therapeutics, Kindred Biosciences, Ambrx, Entest Biomedical, Taconic Biosciences.

Market Segment by Types like Antibiotics, Antifungal, Flea Products and by Application like Cat, Dog, Horse, Fish, Other.

Get Exclusive Sample of Report on Pet Medication market having 108 pages, profiling 16 Leading Market Players https://www.inforgrowth.com/samplerequest/r/341217/global-pet-medication-market-insights-forecast

The report provides information about Pet Medication Market Landscape, Industry History, Development Prospect, Relevant Policy and Trade Overview to current demand, investment and supply in the market. It also shows future opportunities for the forecast years 2018-2025.

Industry chain structure is analyzed by demand of Pet Medication and suppliers along with Cost Analysis, Channel Analysis and technology used for Pet Medication. Market Dynamics gives data about Latest News, Merger and Acquisition of major players, Planned or Future Projects about Pet Medication and Policy Dynamics. Report continues with Import-Export data and country wise market analysis.

The Pet Medication industry development trends are studied through both Secondary and Primary sources. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

 

Major Points from Table of Contents

1 Report Overview

2 Executive Summary

3 Breakdown Data by Manufacturers 

4 Breakdown Data by Type 

5 Breakdown Data by Application 

6 North America 

7 Europe 

8 Asia Pacific 

9 Central & South America 

10 Middle East and Africa 

11 Company Profiles 

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 

13 Value Chain and Sales Channels Analysis 

14 Research Findings and Conclusion 

15 Appendix 

Connect with our expert research team to build custom research on this topic by clicking here https://www.inforgrowth.com/customizationrequest/r/341217/global-pet-medication-market-insights-forecast

Contact Info:
Name: Mr. Rohan
Email: Send Email
Organization: InForGrowth
Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USA
Phone: +1-909-329-2808
Website: https://www.inforgrowth.com/

Source URL: https://marketersmedia.com/pet-medication-market-analysis-and-business-opportunities-with-cagr-value-key-manufactures-revenue-structure-types-applications/481746

Source: MarketersMedia

Release ID: 481746

Latest News

Unicorns are real: Tech baffles Indonesian candidate

Feb 23, 2019

JAKARTA, Indonesia — Indonesia's presidential candidates debated some of the most pressing issues facing the world's third-largest democracy: dilapidated infrastructure, struggling farmers, forest fires — and unicorns. When President Joko Widodo, who is seeking a second term, asked challenger Prabowo Subianto about his policies for supporting unicorns — tech start-up companies worth at least $1 billion — a look of bafflement passed across the former general's face. Wondering aloud, he replied: "What are unicorns? You mean those online things?" Widodo sagely nodded in the affirmative before Subianto explained he supports online businesses. Subianto was probably not alone in his ignorance,...

Asian stocks rally on hope of further China-US trade talks

Feb 23, 2019

SINGAPORE — Asian markets were broadly higher on Monday as traders looked forward to the continuation of trade talks between Chinese and American officials in Washington this week. South Korea's Kospi jumped 0.7 percent to 2,212.38 and the Shanghai Composite index rose 1.6 percent to 2,724.23. Hong Kong's Hang Seng was 1.7 percent higher at 28,359.81. Australia's S&P/ASX 200 added 0.4 percent to 6,089.90. Japan's benchmark Nikkei 225 advanced 1.8 percent to 21,273.16. The country said its core machinery orders dropped 0.1 percent in December from the previous month, beating forecasts of a 1.1 percent decline. Shares rose in Taiwan...

Indonesia land-burning fines unpaid years after fires

Feb 23, 2019

JAKARTA, Indonesia — Indonesian plantation companies fined for burning huge areas of land since 2009 have failed to pay hundreds of millions of dollars in penalties meant to hold them accountable for actions that took a devastating environmental and human toll. The 10 palm oil and pulp wood companies involved in fires owe more than $220 million in fines and the figure for unpaid penalties for environmental destruction swells to $1.3 billion when an illegal logging case from 2013 is included, according to separate summaries of the cases compiled by Greenpeace and the Ministry of Environment and Forestry. Indonesia's annual...

World stocks slip with few leads from US-China talks

Feb 23, 2019

SINGAPORE — World markets were mostly lower on Friday in the absence of good news as the U.S. and China concluded yet another round of trade talks in Beijing. France's CAC 40 rose 0.4 percent to 5,080.31 while the DAX in Germany dipped 0.4 percent to 11,044.17. Britain's FTSE 100 edged up 0.1 percent to 7,202.54. Wall Street was set for losses on the open. S&P 500 futures shed 0.3 percent to 2,735.00. Futures for the Dow were 0.4 percent lower at 25,327.00. European traders were looking out for possible snap elections in Spain. Prime Minister Pedro Sanchez was to...

Asian stocks slip on Wall Street leads as trade talks simmer

Feb 23, 2019

SINGAPORE — Asian shares were broadly lower on Friday, tracking a weak Wall Street session as traders awaited the conclusion of U.S.-China talks in Beijing. Japan's benchmark Nikkei 225 retreated 1.2 percent to 20,886.27 and the Kospi in South Korea tumbled 1.6 percent to 2,189.50. Hong Kong's Hang Seng gave up 1.5 percent to 28,015.65. The Shanghai Composite was 0.6 percent lower at 2,703.60. Australia's S&P/ASX 200 bucked the regional trend, picking up 0.1 percent to 6,062.30. Shares fell Taiwan and throughout Southeast Asia. Disappointing data led U.S indexes to a mixed finish on Thursday. According to the Commerce Department,...

About Us

Pioneered by experienced entrepreneurs, bankers and software engineers, BursaKL stand tall to bring you the latest state of business and finance from Malaysia and all over the world.

Contact us: sales[at]bursakl.com